A Phase 1, open-label, randomized, 3-way crossover study to evaluate the relative bioavailability of a single oral dose of aspirin administered as PA32540 (aspirin/omeprazole) or as the aspirin component of PA32540 or as Ecotrin 325 mg in healthy volunteers
Phase of Trial: Phase I
Latest Information Update: 29 Jan 2010
At a glance
- Drugs Aspirin; Aspirin/omeprazole
- Indications Cardiovascular disorders; Embolism and thrombosis; NSAID-induced gastrointestinal damage
- Focus Pharmacokinetics
- 02 Apr 2008 New trial record.